Letter: not the end of the role of anti-viral therapy in ulcerative colitis with cytomegalovirus reactivation - authors' reply

被引：0
|
作者：
Delvincourt, M. [1 ]
Sokol, H. [1 ,2 ,3 ]
机构：
[1] Assistance Publ Hopitaux Paris & Paris VI Univ, St Antoine Hosp, Dept Gastroenterol, Paris, France
[2] Univ Paris 06, Laboratoire INSERM U1057 UMR CNRS 7203, Paris, France
[3] Commensal & Probiot Host Interact Lab, UMR 1319 Micalis, Jouy En Josas, France
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2014年 / 39卷 / 10期
关键词：
INFECTION;
D O I：
10.1111/apt.12722
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1247 / 1248
页数：2
相关论文
共 50 条
  • [21] Letter: the effects of preoperative infliximab on complications after surgery for ulcerative colitis - authors' reply
    Yang, Z.
    Wu, K.
    Fan, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (11-12) : 1107 - 1108
  • [22] Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects
    Mareri, Arianna
    Lasorella, Stefania
    Iapadre, Giulia
    Maresca, Maria
    Tambucci, Renato
    Nigro, Giovanni
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (10): : 1657 - 1664
  • [23] Letter: pre- and post-operative anti-viral therapy is important for patients with hepatitis B virus-related hepatocellular carcinoma - authors' reply
    Chong, C. C. N.
    Wong, V. W. S.
    Lai, P. B. S.
    Chan, H. L. Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (08) : 790 - 790
  • [24] Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis? authors' reply
    Hart, A. L.
    Ng, S. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (03) : 414 - 415
  • [25] Is propionyl-L-carnitine therapy effective in ulcerative colitis? authors' reply
    Bacchieri, A.
    Camerini, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (02) : 316 - 317
  • [26] Letter: hepatitis B virus reactivation in patients with chronic hepatitis C during direct-acting anti-viral therapy
    Huang, R.
    Yan, X.
    Xia, J.
    Wang, J.
    Wu, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (12) : 1558 - 1558
  • [27] Letter: Critical appraisal of biologic therapy in early ulcerative colitis management-Addressing study limitations and the role of psychological resilience-Authors' reply
    Strande, Vibeke
    Hoivik, Marte Lie
    Kristensen, Vendel A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (06) : 831 - 832
  • [28] Letter: liver involvement and mortality in COVID-19-the role of anti-viral therapy should be considered
    Boglione, Lucio
    Rostagno, Roberto
    Poletti, Federica
    Moglia, Roberta
    Bianchi, Bianca
    Esposito, Maria
    Biffi, Stefano
    Borre, Silvio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (05) : 679 - 680
  • [29] Letter: real-life management of new onset ulcerative colitis and proctitis - authors' reply
    Richter, J. M.
    Barrett, J.
    Oster, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (07) : 686 - 686
  • [30] Letter: acute severe ulcerative colitis - should all patients be treated equally? Authors' reply
    Gleeson, D.
    Heneghan, M. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (01) : 114 - 115
12345